Stock Taper
| DATE | TYPE | RATIO |
|---|---|---|
| 2001-06-04 | Forward | 2:1 |
| 1992-05-11 | Forward | 2:1 |
| 1982-02-02 | Forward | 2:1 |
| 1980-02-04 | Forward | 2:1 |
Revvity, Inc. provides global diagnostic, life sciences, and applied solutions—including instruments, reagents, and services—for research, health screening, environmental analysis, and industrial applications across various markets.

A high-content screening system that accelerates phenotypic screening and cellular analysis by enabling quantitative imaging of complex models like 3D organoids and organ-on-chip, streamlining high-throughput drug discovery.
| Icon | PRODUCT | Q3-2025 | Q4-2025 | Q1-2026 | Q2-2026 |
|---|---|---|---|---|---|
![]() | Diagnostics | $356.13M | $390.07M ▲ | $349.27M ▼ | $370.99M ▲ |
![]() | Life Sciences | $342.82M | $381.99M ▲ | $361.85M ▼ | $358.7M ▼ |
| Map | REGION | Q2-2025 | Q3-2025 | Q1-2026 | Q2-2026 |
|---|---|---|---|---|---|
![]() | Americas | $323.58M | $307.28M ▼ | $315.99M ▲ | $325.58M ▲ |
![]() | Europe | $203.63M | $202.4M ▼ | $223.05M ▲ | $229.04M ▲ |
![]() | Asia | $193.07M | $189.28M ▼ | $172.08M ▼ | $175.06M ▲ |
Overall rating: B
| PEER | PRICE | |
|---|---|---|
GH | $158.63 | COMPARE |
SOLV | $91.34 | COMPARE |
CRL | $287.57 | COMPARE |
ICLR | $165.05 | COMPARE |
ALGN | $158.78 | COMPARE |
RDY | $12.16 | COMPARE |
ENSG | $171.19 | COMPARE |
QGEN | $43.42 | COMPARE |